Site Menu
発表論文 2011年
Links
1.松田 彰
ヌクレアーゼ抵抗性化学修飾核酸の開発研究
薬学雑誌, 2011, 131, 285-298. DOI:10.1248/yakushi.131.285
2.谷野 哲也、市川 聡、魚谷 幸一、大山 洋、松田 彰
新規抗菌剤開発を指向したMraY阻害天然物ムライマイシン類の合成研究
薬学雑誌、2011, 131, 335-346. DOI:10.1248/yakushi.131.335
4.Fruita, K.; Murata, S.; Jee, J. G.; Ichikawa, S.; Matsuda, A.; Kojima, C.
Structural feature of bent DNA recognized by HMGB1.
J. Am. Chem. Soc. 2011, 133, 5788-5790. DOI: 10.1021/ja2013399
7.Ichikawa, S.; Tanino, T.; Ii, K.; Matsuda, A.
Development of antibacterial agents against drug-resistant bacterial pathogens based on total synthesis of nucleoside natural products.
有機合成化学協会誌, 2011, 69, 1020-1033.
9.Taniike, H.; Inagaki, Y.; Matsuda, A.; Minakawa, N.
Practical synthesis of 4´-selenopyrimidine nucleosides using hypervalent iodine.
Tetrahedron 2011, 67, 7977-7982. DOI: 10.1016/j.tet.2011.08.020
11.Meike, S.; Yamamori, T.; Yasui, H.; Eitaki, M.; Matsuda, A.; Inanami, O.
8-Aminoadenosine Enhances Radiation-induced Cell Death in Human Lung Carcinoma A549 Cells.
J. Rad. Res. 2011, 52, 456-463. DOI: 10.1269/jrr.10188
12.Meike, S.; Yamamori, T.; Yasui, H.; Eitaki, M.; Matsuda, A.; Inanami, O.
A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression.
Mol. Cancer 2011, 10, 92-100. DOI: 10.1186/1476-4598-10-92
13.Hori, M.; Suzuki, T.; Minakawa, N.; Matsuda, A.; Harashima, H.; Kamiya, H.
Mutagenicity of secondary oxidation products of 8-oxo-7,8-dihydro-2´-deoxyguanosine 5´-triphosphate (8-hydroxy-2´-deoxyguanosine 5´-triphosphate).
Mutation Res., Fundamental and Molecular Mechanisms of Mutagenesis 2011, 714, 11-16.
DOI: 10.1016/j.mrfmmm.2011.05.015
15.Sato, K.; Sasaki, A.; Matsuda, A.
Highly Fluorescent 5-(5,6-Dimethoxybenzothiazol-2-yl)-2´-Deoxyuridine 5´-Triphosphate as an Efficient Substrate for DNA Polymerases.
ChemBioChem 2011, 12, 2341-2346. DOI: 10.1002/cbic.201100452
Cover Picture of ChemBioChem 2011, 12, issue 15. DOI: 10.1002/cbic.201190069
16.Muranaka, K.; Ichikawa, S.; Matsuda, A.
Development of the Carboxamine Protection Group, 4-(tert-Butyldimethylsiloxy)-2-methoxybenzyl.
J. Org. Chem. 2011, 76, 9278-9293. DOI: 10.1021/jo201495w
17.Tanino, T.; Al-Dabbagh, B.; Mengin-Lecreulx, D.; Bouhss, A.; Oyama, H.; Ichikawa, S.; Matsuda, A.
Mechanistic Analysis of Muraymycin Analogues: A Guide to the Design of MraY Inhibitors.
J. Med. Chem. 2011, 54, 8421-8439. DOI: 10.1021/jm200906r
All Rights Reserved Laboratory of Medicinal Chemistry